Cutting Edge Therapeutics, Inc (CET) is a start-up biopharmaceutical company focused on licensing and developing a portfolio of exciting and innovative therapeutics for CNS disorders, Cancer and Infectious Diseases. We are dedicated to finding cutting edge treatments to address unmet medical needs worldwide. We are committed to building a portfolio of new therapies to meet the growing cases. CET is hoping to be the first to market novel therapeutics in the emerging field of oncology, neurology and immunotheraphy.